Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Boots NicAssist 7mg/24hours transdermal patches
0410020B0BHAZAP
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist Fruit Fresh 2mg medicated chewing gum
0410020B0BHAQBA
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist Fruit Fresh 4mg medicated chewing gum
0410020B0BHARBD
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist Ice Mint 2mg medicated chewing gum
0410020B0BHBBBA
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist Ice Mint 4mg medicated chewing gum
0410020B0BHBCBD
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist Minty Fresh 2mg medicated chewing gum
0410020B0BHAIBA
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist Minty Fresh 4mg medicated chewing gum
0410020B0BHAJBD
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist Translucent 10mg/16hours patches
0410020B0BHATAT
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist Translucent 15mg/16hours patches
0410020B0BHAVAU
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist Translucent 25mg/16hours patches
0410020B0BHAWBR
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots Nicotine 14mg/24hours patches
0410020B0BHADAQ
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots Nicotine 21mg/24hours patches
0410020B0BHACAR
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots Nicotine 2mg medicated chewing gum
0410020B0BHAGBA
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots Nicotine 4mg medicated chewing gum
0410020B0BHAFBD
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NRT 7mg/24hours patches
0410020B0BHAEAP
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Galpharm Nicotine Replace 2mg lozenges
0410020B0BMAAAY
|
Galpharm nicotine | Nicotine | Central Nervous System | No data available |
|
Galpharm Nicotine Replace 2mg medicated chewing gum
0410020B0BMACBA
|
Galpharm nicotine | Nicotine | Central Nervous System | No data available |
|
Galpharm Nicotine Replace 4mg lozenges
0410020B0BMABAZ
|
Galpharm nicotine | Nicotine | Central Nervous System | No data available |
|
Galpharm Nicotine Replace 4mg medicated chewing gum
0410020B0BMADBD
|
Galpharm nicotine | Nicotine | Central Nervous System | No data available |
|
Nicobrevin capsules
0410020B0BKAAA0
|
Proprietary compound preparation BNF 0410020 | Nicotine | Central Nervous System | No data available |
|
Nicopass 1.5mg Fresh Mint lozenges
0410020B0BJAABP
|
Nicopass | Nicotine | Central Nervous System | No data available |
|
Nicopass 1.5mg Liquorice Mint lozenges
0410020B0BJABBP
|
Nicopass | Nicotine | Central Nervous System | No data available |
|
Nicopatch 14mg/24hours transdermal patches
0410020B0BIABAQ
|
Nicopatch | Nicotine | Central Nervous System | No data available |
|
Nicopatch 21mg/24hours transdermal patches
0410020B0BIACAR
|
Nicopatch | Nicotine | Central Nervous System | No data available |
|
Nicopatch 7mg/24hours transdermal patches
0410020B0BIAAAP
|
Nicopatch | Nicotine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.